Related Experiment Videos
Defining CD95 as a tumor suppressor gene
M Müschen1, U Warskulat, M W Beckmann
1Institute of Genetics, Department of Immunology and Medizinische Klinik I, Universität zu Köln, Cologne, Germany. markus.mueschen@uni-koeln.de
Abstract:
The CD95 (Apo-1/Fas) receptor-ligand system is one of the key regulators of apoptosis and is particularly important for the maintenance of lymphocyte homeostasis. There is now broad evidence that susceptibility of tumor cells towards CD95-mediated apoptosis is largely reduced. In the human, germline and somatic mutations of the CD95 gene are associated with a high risk of both lymphoid and solid tumors. Based on these observations a new concept defining CD95 as a tumor suppressor gene is discussed. In addition to CD95, its natural ligand (CD95L) is also implicated in malignant progression. Compared to their nonmalignant counterparts, malignant cells frequently exhibit aberrant de novo expression of CD95L and are able to induce CD95L-mediated apoptosis in bystander cells. The role for neoplastic CD95L expression in local tissue destruction, invasion, and metastatic spread has been established for many tumor types. CD95L expression by malignant cells may counteract the host's antitumor immunity and favors immune escape of the tumor. On this basis, the significance of loss of CD95 and gain of CD95L expression for tumor progression is discussed.
Insights
The CD95 (Apo-1/Fas) receptor system regulates apoptosis and lymphocyte balance. Mutations in the CD95 gene increase tumor risk, suggesting CD95 acts as a tumor suppressor, while CD95L expression promotes cancer progression.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- The CD95 (Apo-1/Fas) receptor-ligand system is crucial for apoptosis and lymphocyte homeostasis.
- Tumor cells often exhibit reduced susceptibility to CD95-mediated apoptosis.
- Mutations in the CD95 gene are linked to increased risk of lymphoid and solid tumors.
Purpose of the Study:
- To discuss the role of CD95 as a tumor suppressor gene.
- To explore the implications of CD95 ligand (CD95L) expression in malignant progression.
- To analyze the significance of CD95 and CD95L expression in tumor development.
Main Methods:
- Literature review and conceptual discussion.
- Analysis of evidence linking CD95 mutations to cancer risk.
- Examination of studies on CD95L expression in various tumor types.
Main Results:
- CD95 mutations are associated with high risks of lymphoid and solid tumors.
- Malignant cells often express CD95L aberrantly, inducing apoptosis in bystander cells.
- Neoplastic CD95L expression contributes to local tissue destruction, invasion, and metastasis.
Conclusions:
- CD95 functions as a tumor suppressor gene.
- Aberrant CD95L expression by tumors promotes malignant progression and immune evasion.
- Dysregulation of the CD95 system (loss of CD95, gain of CD95L) is significant for tumor progression.